Top Markets
Coin of the day
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Classifica tra le azioni #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Prezzo delle azioni
$0.00953895
Ultima sincronizzazione: 2024-05-22
Capitalizzazione di mercato
$1.28M
Variazione (1 giorno)
0.06%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Evgen Pharma plc (EVG)

Categoria

Storico del prezzo dell'azione per Evgen Pharma plc (EVG)
Prezzo di chiusura più alto: $0.01 il 2024-05-01

Prezzo di chiusura più basso: $0.49 il 2015-10-01
Storico del prezzo dell'azione di Evgen Pharma plc dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -54.58%
2023 -67.00%
2022 -8.24%
2021 -46.45%
2020 34.51%
2019 -54.10%
2018 2.85%
2017 -28.77%
2016 -24.59%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE